RISING PHARMACEUTICALS recalls Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brun…

Recall date

September 2, 2021

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0005-2022

FDA classification

Class II

Brand / firm

RISING PHARMACEUTICALS

Sold / distributed

to be entered

Why it was recalled

Labeling: Incorrect Instructions

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01